Arbor Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2014-01-06
Last Posted Date
2022-04-13
Lead Sponsor
Arbor Pharmaceuticals, Inc.
Target Recruit Count
17
Registration Number
NCT02027155
Locations
🇺🇸

Duke Clinical Research Unit, Durham, North Carolina, United States

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

First Posted Date
2013-11-18
Last Posted Date
2020-07-21
Lead Sponsor
Arbor Pharmaceuticals, Inc.
Target Recruit Count
97
Registration Number
NCT01986062
Locations
🇺🇸

Florida Clinical Research Center, LLC., Bradenton, Florida, United States

🇺🇸

Bayou City Research Ltd., Houston, Texas, United States

🇺🇸

Westex Clinical Investigations, Houston, Texas, United States

and more 4 locations

AR08 for Treatment of ADHD in Children

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-06-13
Last Posted Date
2015-12-09
Lead Sponsor
Arbor Pharmaceuticals, Inc.
Target Recruit Count
122
Registration Number
NCT01876719
Locations
🇺🇸

Janus Center for Psychiatric Research, West Palm Beach, Florida, United States

🇺🇸

Houston Clinical Trials, Houston, Texas, United States

🇺🇸

Florida Clinical Research Center, LLC, Brandenton, Florida, United States

and more 9 locations

Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-05-01
Last Posted Date
2015-05-04
Lead Sponsor
Arbor Pharmaceuticals, Inc.
Target Recruit Count
38
Registration Number
NCT01588535
Locations
🇺🇸

DiscoveReseach, Inc., Bryan, Texas, United States

🇺🇸

COMMUNITY Medical Research, Miami Beach, Florida, United States

🇺🇸

Nda Baptist Clinic, Jonesboro, Arkansas, United States

and more 11 locations

A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2012-04-30
Last Posted Date
2015-08-06
Lead Sponsor
Arbor Pharmaceuticals, Inc.
Target Recruit Count
36
Registration Number
NCT01587313
Locations
🇺🇸

Frontage Cinical Services, Hackensack, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath